Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.
Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.
Pulmonary Fibrosis Awareness Month: Let the World Know!
Join three members from the PFF team, Amy Wardzala, Kate Gates, and Samantha Simmons, to learn how your support makes our programs and services for patients and their families possible, and explore ways that you make a difference this September.
PF Genes and Families: The Role of Genetic Counseling
Genetic Counselor Janet Talbert, MS, CGC, LGC will offer information about genes associated with PF, discuss the benefits and considerations of genetic testing, and offer guidance for those seeking counseling.
PFF Senior Medical Advisor Amy Hajari Case will host by PFF Scholars Gillian Goobie, MD, FRCPC, and Jeremy Katzen, MD for a review of current clinical studies and a report on their PFF-supported research. Register now to join us for this informative presentation.